vs

Side-by-side financial comparison of Bloomin' Brands, Inc. (BLMN) and Western Midstream Partners, LP (WES). Click either name above to swap in a different company.

Western Midstream Partners, LP is the larger business by last-quarter revenue ($1.0B vs $975.2M, roughly 1.1× Bloomin' Brands, Inc.). Western Midstream Partners, LP runs the higher net margin — 18.5% vs -1.4%, a 19.9% gap on every dollar of revenue. On growth, Western Midstream Partners, LP posted the faster year-over-year revenue change (11.0% vs 0.3%). Western Midstream Partners, LP produced more free cash flow last quarter ($335.4M vs $63.7M). Over the past eight quarters, Western Midstream Partners, LP's revenue compounded faster (7.8% CAGR vs -4.5%).

Bloomin' Brands, Inc. is a restaurant holding company that owns several American casual dining restaurant chains. The company was established in 1988 in Tampa, Florida, where it is headquartered.

Sunoco LP is an American vehicle gasoline master limited partnership company organized under Delaware state law and headquartered in Dallas, Texas. Dating back to 1886, the company has transformed from a vertically integrated energy company to a distributor of fuels and operator of energy infrastructure. It was previously engaged in oil, natural gas exploration and production, refining, chemical manufacturing, and retail fuel sales, but divested these businesses.

BLMN vs WES — Head-to-Head

Bigger by revenue
WES
WES
1.1× larger
WES
$1.0B
$975.2M
BLMN
Growing faster (revenue YoY)
WES
WES
+10.6% gap
WES
11.0%
0.3%
BLMN
Higher net margin
WES
WES
19.9% more per $
WES
18.5%
-1.4%
BLMN
More free cash flow
WES
WES
$271.8M more FCF
WES
$335.4M
$63.7M
BLMN
Faster 2-yr revenue CAGR
WES
WES
Annualised
WES
7.8%
-4.5%
BLMN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BLMN
BLMN
WES
WES
Revenue
$975.2M
$1.0B
Net Profit
$-13.5M
$190.7M
Gross Margin
70.2%
Operating Margin
-1.4%
29.7%
Net Margin
-1.4%
18.5%
Revenue YoY
0.3%
11.0%
Net Profit YoY
83.0%
-42.8%
EPS (diluted)
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLMN
BLMN
WES
WES
Q4 25
$975.2M
$1.0B
Q3 25
$928.8M
$952.3M
Q2 25
$1.0B
$942.1M
Q1 25
$1.0B
$916.9M
Q4 24
$972.0M
$928.4M
Q3 24
$910.0M
$883.1M
Q2 24
$999.4M
$905.4M
Q1 24
$1.1B
$887.3M
Net Profit
BLMN
BLMN
WES
WES
Q4 25
$-13.5M
$190.7M
Q3 25
$-45.9M
$339.6M
Q2 25
$25.4M
$341.7M
Q1 25
$42.2M
$309.0M
Q4 24
$-79.5M
$333.6M
Q3 24
$6.9M
$288.5M
Q2 24
$28.4M
$378.6M
Q1 24
$-83.9M
$572.8M
Gross Margin
BLMN
BLMN
WES
WES
Q4 25
70.2%
Q3 25
70.4%
Q2 25
70.2%
Q1 25
70.1%
Q4 24
71.6%
Q3 24
71.3%
Q2 24
70.5%
Q1 24
70.5%
Operating Margin
BLMN
BLMN
WES
WES
Q4 25
-1.4%
29.7%
Q3 25
-3.9%
46.4%
Q2 25
3.0%
47.2%
Q1 25
5.5%
44.7%
Q4 24
1.7%
45.9%
Q3 24
0.9%
44.8%
Q2 24
4.4%
51.9%
Q1 24
6.6%
76.6%
Net Margin
BLMN
BLMN
WES
WES
Q4 25
-1.4%
18.5%
Q3 25
-4.9%
35.7%
Q2 25
2.5%
36.3%
Q1 25
4.0%
33.7%
Q4 24
-8.2%
35.9%
Q3 24
0.8%
32.7%
Q2 24
2.8%
41.8%
Q1 24
-7.8%
64.6%
EPS (diluted)
BLMN
BLMN
WES
WES
Q4 25
$-0.16
Q3 25
$-0.54
Q2 25
$0.30
Q1 25
$0.50
Q4 24
$-0.93
Q3 24
$0.08
Q2 24
$0.32
Q1 24
$-0.96

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLMN
BLMN
WES
WES
Cash + ST InvestmentsLiquidity on hand
$59.5M
$819.5M
Total DebtLower is stronger
$787.4M
$8.2B
Stockholders' EquityBook value
$333.6M
Total Assets
$3.2B
$15.0B
Debt / EquityLower = less leverage
2.36×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLMN
BLMN
WES
WES
Q4 25
$59.5M
$819.5M
Q3 25
$66.5M
$177.3M
Q2 25
$50.3M
$129.7M
Q1 25
$57.7M
$448.4M
Q4 24
$70.1M
$1.1B
Q3 24
$83.6M
$1.1B
Q2 24
$117.9M
$344.1M
Q1 24
$131.7M
$295.2M
Total Debt
BLMN
BLMN
WES
WES
Q4 25
$787.4M
$8.2B
Q3 25
$962.2M
$6.9B
Q2 25
$917.1M
$6.9B
Q1 25
$917.6M
$6.9B
Q4 24
$1.0B
$6.9B
Q3 24
$1.1B
$6.9B
Q2 24
$1.0B
$7.1B
Q1 24
$951.8M
$7.3B
Stockholders' Equity
BLMN
BLMN
WES
WES
Q4 25
$333.6M
Q3 25
$344.1M
Q2 25
$397.2M
Q1 25
$380.6M
Q4 24
$135.5M
Q3 24
$242.1M
Q2 24
$286.8M
Q1 24
$302.7M
Total Assets
BLMN
BLMN
WES
WES
Q4 25
$3.2B
$15.0B
Q3 25
$3.3B
$12.1B
Q2 25
$3.3B
$12.2B
Q1 25
$3.3B
$12.5B
Q4 24
$3.4B
$13.1B
Q3 24
$3.4B
$13.0B
Q2 24
$3.4B
$12.2B
Q1 24
$3.4B
$12.3B
Debt / Equity
BLMN
BLMN
WES
WES
Q4 25
2.36×
Q3 25
2.80×
Q2 25
2.31×
Q1 25
2.41×
Q4 24
7.58×
Q3 24
4.51×
Q2 24
3.49×
Q1 24
3.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLMN
BLMN
WES
WES
Operating Cash FlowLast quarter
$119.1M
$557.6M
Free Cash FlowOCF − Capex
$63.7M
$335.4M
FCF MarginFCF / Revenue
6.5%
32.6%
Capex IntensityCapex / Revenue
5.7%
21.6%
Cash ConversionOCF / Net Profit
2.92×
TTM Free Cash FlowTrailing 4 quarters
$96.8M
$1.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLMN
BLMN
WES
WES
Q4 25
$119.1M
$557.6M
Q3 25
$34.4M
$570.2M
Q2 25
$49.7M
$564.0M
Q1 25
$73.5M
$530.8M
Q4 24
$119.8M
$554.4M
Q3 24
$-7.8M
$551.3M
Q2 24
$42.4M
$631.4M
Q1 24
$73.8M
$399.7M
Free Cash Flow
BLMN
BLMN
WES
WES
Q4 25
$63.7M
$335.4M
Q3 25
$-5.7M
$385.5M
Q2 25
$11.1M
$385.4M
Q1 25
$27.7M
$388.4M
Q4 24
$66.7M
$315.7M
Q3 24
$-67.3M
$361.9M
Q2 24
$-12.1M
$419.6M
Q1 24
$20.0M
$205.9M
FCF Margin
BLMN
BLMN
WES
WES
Q4 25
6.5%
32.6%
Q3 25
-0.6%
40.5%
Q2 25
1.1%
40.9%
Q1 25
2.6%
42.4%
Q4 24
6.9%
34.0%
Q3 24
-7.4%
41.0%
Q2 24
-1.2%
46.3%
Q1 24
1.9%
23.2%
Capex Intensity
BLMN
BLMN
WES
WES
Q4 25
5.7%
21.6%
Q3 25
4.3%
19.4%
Q2 25
3.8%
19.0%
Q1 25
4.4%
15.5%
Q4 24
5.5%
25.7%
Q3 24
6.5%
21.5%
Q2 24
5.5%
23.4%
Q1 24
5.0%
21.8%
Cash Conversion
BLMN
BLMN
WES
WES
Q4 25
2.92×
Q3 25
1.68×
Q2 25
1.95×
1.65×
Q1 25
1.74×
1.72×
Q4 24
1.66×
Q3 24
-1.13×
1.91×
Q2 24
1.49×
1.67×
Q1 24
0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLMN
BLMN

Food And Beverage$958.0M98%
Franchiseand Other Revenue$17.2M2%
International Franchise Segment$7.8M1%

WES
WES

Segment breakdown not available.

Related Comparisons